H.R. 2279, S. 2546 - Safe Step Act
Fiscal Year 2021 Labor, HHS Appropriations Act and CDC support for chronic disease education, awareness and related activities
Concerns regarding psoriatic disease and military service.
Duration: March 1, 2014
to
January 31, 2020
General Issues: Health Issues , Budget/Appropriations , Defense , Medicare/Medicaid , Medical/Disease Research/Clinical Labs
Spending: about $260,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2014: U.S. Senate, House of Representatives, Health & Human Services - Dept of (HHS), Centers For Disease Control & Prevention (CDC), White House Office
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2020
Faegre Baker Daniels Consulting terminated an engagement in which they represented National Psoriasis Foundation on April 17, 2020.
Original Filing: 301169312.xml
Lobbying Issues
H.R. 2279, S. 2546 - Safe Step Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Fiscal Year 2021 Labor, HHS Appropriations Act and CDC support for chronic disease education, awareness and related activities
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Concerns regarding psoriatic disease and military service.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2019
In Q4, Faegre Baker Daniels Consulting lobbied for National Psoriasis Foundation , earning $20,000. The report was filed on Jan. 21, 2020.
Original Filing: 301124994.xml
Lobbying Issues
H.R. 2279, S. 2546 - Safe Step Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Fiscal Year 2020 Labor HHS appropriations and funding for public health activities focused on psoriasis and psoriatic arthritis.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Concerns regarding psoriatic disease and military service.
3rd Quarter, 2019
In Q3, Faegre Baker Daniels Consulting lobbied for National Psoriasis Foundation , earning $20,000. The report was filed on Oct. 17, 2019.
Original Filing: 301067342.xml
Lobbying Issues
H.R. 2279, S. 2546 - Safe Step Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Fiscal Year 2020 Labor HHS appropriations and funding for public health activities focused on psoriasis and psoriatic arthritis.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Concerns regarding psoriatic disease and military service.
2nd Quarter, 2019
In Q2, Faegre Baker Daniels Consulting lobbied for National Psoriasis Foundation , earning $20,000. The report was filed on July 19, 2019.
Original Filing: 301050991.xml
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Fiscal Year 2020 Labor HHS appropriations and funding for public health activities focused on psoriasis and psoriatic arthritis.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2019
In Q1, Faegre Baker Daniels Consulting lobbied for National Psoriasis Foundation , earning $10,000. The report was filed on April 19, 2019.
Original Filing: 301031592.xml
Lobbying Issues
Public health agenda for psoriasis and psoriatic arthritis; reintroduction of step-therapy legislation.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Disease Control & Prevention (CDC)
Lobbying Issues
Fiscal Year 2020 Labor HHS appropriations and funding for public health activities focused on psoriasis and psoriatic arthritis.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Policies pertaining to utilization management policies in Medicare Part B and D; Proposed Part D Rebate Rule
4th Quarter, 2018
In Q4, Faegre Baker Daniels Consulting lobbied for National Psoriasis Foundation , earning $10,000. The report was filed on Jan. 18, 2019.
Original Filing: 301007669.xml
Lobbying Issues
Public health agenda for psoriasis and psoriatic arthritis; Restoring the Patients Voice Act (HR 2077)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Disease Control & Prevention (CDC)
Lobbying Issues
Fiscal year 2019 labor HHS appropriations
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Policies pertaining to utilization management policies in Medicare Part B and D; Proposed Part B Demonstration
3rd Quarter, 2018
In Q3, Faegre Baker Daniels Consulting lobbied for National Psoriasis Foundation , earning $10,000. The report was filed on Oct. 19, 2018.
Original Filing: 300993028.xml
Lobbying Issues
Public health agenda for psoriasis and psoriatic arthritis; Restoring the Patients Voice Act (HR 2077); Patients Access to Treatment Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Disease Control & Prevention (CDC)
Lobbying Issues
Fiscal year 2019 labor HHS appropriations
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Policies pertaining to utilization management policies in Medicare Part B and D
2nd Quarter, 2018
In Q2, Faegre Baker Daniels Consulting lobbied for National Psoriasis Foundation , earning $20,000. The report was filed on July 20, 2018.
Original Filing: 300976185.xml
Lobbying Issues
Public health agenda for psoriasis and psoriatic arthritis; Restoring the Patients Voice Act (HR 2077); Patients Access to Treatment Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Disease Control & Prevention (CDC)
Lobbying Issues
Fiscal year 2019 labor HHS appropriations
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2018
In Q1, Faegre Baker Daniels Consulting lobbied for National Psoriasis Foundation , earning $20,000. The report was filed on April 18, 2018.
Original Filing: 300946813.xml
Lobbying Issues
Public health agenda for psoriasis and psoriatic arthritis; Restoring the Patients Voice Act (HR 2077); Patients Access to Treatment Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Disease Control & Prevention (CDC)
Lobbying Issues
Fiscal year 2019 HHS appropriations
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Research and public health funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2017
In Q4, Faegre Baker Daniels Consulting lobbied for National Psoriasis Foundation , earning $20,000. The report was filed on Jan. 19, 2018.
Original Filing: 300929379.xml
Lobbying Issues
Public health agenda for psoriasis and psoriatic arthritis; Restoring the Patients Voice Act (HR 2077); Patients Access to Treatment Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Disease Control & Prevention (CDC)
Lobbying Issues
Medical reimbursement levels
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC)
Lobbying Issues
CDC appropriations; research and public health funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Research and public health funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2017
In Q3, Faegre Baker Daniels Consulting lobbied for National Psoriasis Foundation , earning $20,000. The report was filed on Oct. 19, 2017.
Original Filing: 300910729.xml
Lobbying Issues
Public health agenda for psoriasis and psoriatic arthritis; Patient's Access to Treatment Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Disease Control & Prevention (CDC)
Lobbying Issues
Medical reimbursement levels
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC)
Lobbying Issues
CDC appropriations; research and public health funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2017
In Q2, Faegre Baker Daniels Consulting lobbied for National Psoriasis Foundation , earning $10,000. The report was filed on July 20, 2017.
Original Filing: 300896303.xml
Lobbying Issues
Public health agenda for psoriasis and psoriatic arthritis; Patient's Access to Treatment Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Disease Control & Prevention (CDC)
Lobbying Issues
Medical reimbursement levels
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC)
Lobbying Issues
Appropriations; research and public health funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2017
In Q1, Faegre Baker Daniels Consulting (f/k/a FaegreBD Consulting) lobbied for National Psoriasis Foundation , earning $10,000. The report was filed on April 19, 2017.
Original Filing: 300869138.xml
Lobbying Issues
Public health agenda for psoriasis and psoriatic arthritis; Patient's Access to Treatment Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Medical reimbursement levels
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC)
Lobbying Issues
Appropriations; research and public health funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2016
In Q4, FaegreBD Consulting lobbied for National Psoriasis Foundation . The report was filed on Jan. 17, 2017.
Original Filing: 300847753.xml
Lobbying Issues
Public health agenda for psoriasis and psoriatic arthritis; Patient's Access to Treatment Act; medical reimbursement levels; 21st Century Cures Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Medical reimbursement levels; appropriations
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC)
Lobbying Issues
Appropriations; research and public health funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2016
In Q3, FaegreBD Consulting lobbied for National Psoriasis Foundation . The report was filed on Oct. 17, 2016.
Original Filing: 300828536.xml
Lobbying Issues
Public health agenda for psoriasis and psoriatic arthritis; Patient's Access to Treatment Act; medical reimbursement levels; 21st Century Cures Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Medical reimbursement levels; appropriations
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC)
Lobbying Issues
Appropriations; research and public health funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2016
In Q2, FaegreBD Consulting lobbied for National Psoriasis Foundation . The report was filed on July 20, 2016.
Original Filing: 300818026.xml
Lobbying Issues
Public health agenda for psoriasis and psoriatic arthritis; Patient's Access to Treatment Act; medical reimbursement levels; 21st Century Cures Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Medical reimbursement levels; appropriations
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC)
Lobbying Issues
Appropriations; research and public health funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2016
In Q1, FaegreBD Consulting lobbied for National Psoriasis Foundation , earning $10,000. The report was filed on April 19, 2016.
Original Filing: 300796430.xml
Lobbying Issues
Public health agenda for psoriasis and psoriatic arthritis; Patient's Access to Treatment Act; Part D Beneficiary Appeals Act; medical reimbursement levels; 21st Century Cures Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Medical reimbursement levels; appropriations
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC)
Lobbying Issues
Appropriations; research and public health funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2015
In Q4, FaegreBD Consulting lobbied for National Psoriasis Foundation . The report was filed on Jan. 20, 2016.
Original Filing: 300782813.xml
Lobbying Issues
Public health agenda for psoriasis and psoriatic arthritis; Patient's Access to Treatment Act; Part D Beneficiary Appeals Act; medical reimbursement levels; 21st Century Cures Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Medical reimbursement levels; appropriations
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC)
Lobbying Issues
Appropriations; research and public health funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2015
In Q3, FaegreBD Consulting lobbied for National Psoriasis Foundation , earning $10,000. The report was filed on Oct. 20, 2015.
Original Filing: 300761664.xml
Lobbying Issues
Public health agenda for psoriasis and psoriatic arthritis; Patient's Access to Treatment Act; Part D Beneficiary Appeals Act; medical reimbursement levels; 21st Century Cures Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Medical reimbursement levels; appropriations
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC)
Lobbying Issues
Appropriations; research and public health funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2015
In Q2, FaegreBD Consulting lobbied for National Psoriasis Foundation . The report was filed on July 16, 2015.
Original Filing: 300737443.xml
Lobbying Issues
Public health agenda for psoriasis and psoriatic arthritis; Patient's Access to Treatment Act; Part D Beneficiary Appeals Act; medical reimbursement levels; 21st Century Cures Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Medical reimbursement levels; appropriations
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC)
Lobbying Issues
Appropriations; research and public health funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2015
In Q1, FaegreBD Consulting lobbied for National Psoriasis Foundation . The report was filed on April 20, 2015.
Original Filing: 300722573.xml
Lobbying Issues
Public health agenda for psoriasis and psoriatic arthritis; Patient's Access to Treatment Act; Part D Beneficiary Appeals Act; medical reimbursement levels
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Medical reimbursement levels; appropriations
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Appropriations; research and public health funding
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2014
In Q4, FaegreBD Consulting lobbied for National Psoriasis Foundation . The report was filed on Jan. 14, 2015.
Original Filing: 300695202.xml
Lobbying Issues
Appropriations; Public Health agenda for psoriasis and psoriatic arthritis; Patient's Access to Treatment Act; Part D Beneficiary Appeals Fairness Act; Medical reimbursement levels
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Medical reimbursement levels; Appropriations
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2014
In Q3, FaegreBD Consulting lobbied for National Psoriasis Foundation , earning $10,000. The report was filed on Oct. 16, 2014.
Original Filing: 300677523.xml
Lobbying Issues
Appropriations; Public health agenda for psoriasis and psoriatic arthritis; patient's Access to Treatments Act; Part D Beneficiary Appeals Fairness Act; Medical reimbursement levels
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Medical Reimbursement levels
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2014
In Q2, FaegreBD Consulting lobbied for National Psoriasis Foundation , earning $20,000. The report was filed on July 17, 2014.
Original Filing: 300659868.xml
Lobbying Issues
Appropriations; Public health agenda for psoriasis and psoriatic arthritis; Patient's Acecess to Treatments Act; Part D Beneficiary Appeals Fairness Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2014
In Q1, FaegreBD Consulting lobbied for National Psoriasis Foundation , earning $10,000. The report was filed on April 21, 2014.
Original Filing: 300646155.xml
Lobbying Issues
Appropriations; Public health agenda for psoriasis and psoriatic arthritis; Patient's Access to Treatments Act; Part D Beneficiary Appeals Fairness Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Health Issues Budget/Appropriations
1st Quarter, 2014
FaegreBD Consulting filed a lobbying registration on April 15, 2014 to represent National Psoriasis Foundation, effective March 1, 2014.
Original Filing: 300637955.xml
Issue(s) they said they’d lobby about: Appropriations; Public Health agenda for Psoriasis and Psoriatic Arthritis; Patient's Access to Treatments Act; Part D Beneficiary Appeals Fairness Act .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate